Literature DB >> 15003672

Varicella zoster antibodies in healthcare workers from two neonatal units in São Paulo, Brazil--assessment of a staff varicella policy.

A M N Santos1, E Ono, L Y Weckx, A P Coutinho, M I de Moraes-Pinto.   

Abstract

Although frequently reported in the literature, a staff varicella policy is not standard in many hospitals even in developed countries. In the present study, we assessed varicella zoster immunity in staff from two neonatal units from hospitals in São Paulo, Brazil. Ninety-seven percent of all staff working in both units agreed to participate. A simple and cost-effective varicella policy was subsequently set up, based on costs and data from serology and a history of previous varicella infection. Our results confirm that a varicella vaccination programme can be implemented in a healthcare facility, even in developing countries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003672     DOI: 10.1016/j.jhin.2003.12.007

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

Review 1.  A systematic review of health economic evaluations of vaccines in Brazil.

Authors:  Ana Marli Christovam Sartori; Luciana Martins Rozman; Tassia Cristina Decimoni; Roseli Leandro; Hillegonda Maria Dutilh Novaes; Patrícia Coelho de Soárez
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

2.  Seroepidemiology of varicella zoster virus in healthcare workers in Babol, Northern Iran.

Authors:  Masomeh Bayani; Mohammad Reza Hasanjani-Roushan; Sepideh Siadati; Mostafa Javanian; Mahmoud Sadeghi-Haddad-Zavareh; Mehran Shokri; Mehdi Mohammadpour; Amin Zarghami; Samaneh Asghari
Journal:  Caspian J Intern Med       Date:  2013

3.  Varicella Seroprevalence in Healthcare Workers at a Medical Center Following Changes in National and Local Hospital Vaccination Policies.

Authors:  Meng-Ting Tsou; Hsin-Hui Shao
Journal:  Int J Environ Res Public Health       Date:  2019-09-22       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.